FHIR IG analytics

Resources that use this resource

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "CodeSystem",
  "id": "med-clinical-category-cs",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs",
  "version": "0.1.0",
  "name": "MedClinicalCategoryCS",
  "title": "Kenya Medication Clinical Category Code System",
  "status": "active",
  "experimental": false,
  "date": "2026-06-08T10:30:33+00:00",
  "publisher": "Digital Health Agency (DHA), Kenya",
  "contact": [
    {
      "name": "Digital Health Agency (DHA), Kenya",
      "telecom": [
        {
          "system": "url",
          "value": "https://dha.go.ke"
        },
        {
          "system": "email",
          "value": "info@dha.go.ke"
        }
      ]
    },
    {
      "name": "Digital Health Agency Kenya – FHIR Team",
      "telecom": [
        {
          "system": "email",
          "value": "info@dha.go.ke",
          "use": "work"
        },
        {
          "system": "url",
          "value": "https://dha.go.ke",
          "use": "work"
        }
      ]
    }
  ],
  "description": "Codes classifying the clinical role of a medication within an oncology regimen.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "KE",
          "display": "Kenya"
        }
      ]
    }
  ],
  "caseSensitive": true,
  "content": "complete",
  "count": 10,
  "concept": [
    {
      "code": "CHEMOTHERAPY",
      "display": "Chemotherapy",
      "definition": "Cytotoxic agent used to kill or inhibit cancer cells."
    },
    {
      "code": "IMMUNOTHERAPY",
      "display": "Immunotherapy",
      "definition": "Agent that stimulates the immune system against cancer."
    },
    {
      "code": "TARGETED-THERAPY",
      "display": "Targeted Therapy",
      "definition": "Agent targeting specific molecular markers on cancer cells."
    },
    {
      "code": "HORMONAL-THERAPY",
      "display": "Hormonal Therapy",
      "definition": "Agent that blocks or modifies hormone-driven tumour growth."
    },
    {
      "code": "SUPPORTIVE-CARE",
      "display": "Supportive Care",
      "definition": "Medication to manage side effects or improve tolerability."
    },
    {
      "code": "ANTI-EMETIC",
      "display": "Anti-emetic",
      "definition": "Agent to prevent or treat nausea and vomiting."
    },
    {
      "code": "GROWTH-FACTOR",
      "display": "Growth Factor",
      "definition": "Colony-stimulating factor to support blood cell recovery."
    },
    {
      "code": "CORTICOSTEROID",
      "display": "Corticosteroid",
      "definition": "Steroid given as part of or to support the oncology regimen."
    },
    {
      "code": "BISPHOSPHONATE",
      "display": "Bisphosphonate",
      "definition": "Agent for prevention or treatment of bone metastasis."
    },
    {
      "code": "ANALGESIC",
      "display": "Analgesic",
      "definition": "Pain management medication in the cancer care context."
    }
  ]
}